| Literature DB >> 18676017 |
Sridhar Srinivasan1, Charles A Schiffer.
Abstract
The occurrence of multiple myeloma and chronic lymphocytic leukemia in the same patient is very uncommon. The immunomodulatory agent lenalidomide has been shown to have high response rates in multiple myeloma and appears to be quite active in advanced CLL. We report two patients with concurrent CLL and MM who were both treated successfully with lenalidomide.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18676017 DOI： 10.1016/j.leukres.2008.06.024
Source DB: PubMed Journal: Leuk Res ISSN： 0145-2126 Impact factor: 3.156